Statute Details
- Title: Health Products (Cosmetic Products — Import for Re-export and Manufacture for Export) Regulations 2019
- Act Code: HPA2007-S656-2019
- Legislative Type: Subsidiary Legislation (SL)
- Authorising Act: Health Products Act (Cap. 122D)
- Enacting Authority: Health Sciences Authority (HSA), with Minister for Health approval
- Commencement: 1 January 2020
- Regulatory Focus: Cosmetic products imported solely for re-export and cosmetic products manufactured solely for export
- Key Provisions: Section 3 (Mercury content of cosmetic products)
- Schedule: Mercury content of cosmetic products (preservative limits for specified products)
What Is This Legislation About?
The Health Products (Cosmetic Products — Import for Re-export and Manufacture for Export) Regulations 2019 (“the Regulations”) create a targeted regulatory framework for certain cosmetic products that are not intended for the Singapore market. In particular, the Regulations govern (i) cosmetic products imported into Singapore solely for re-export, and (ii) cosmetic products manufactured in Singapore solely for export. The practical effect is that even where goods are merely transiting through Singapore or being produced for overseas markets, Singapore law still imposes specific safety-related constraints.
At the centre of the Regulations is a prohibition on excessive mercury content in cosmetic products. Mercury is a toxic substance with well-established health risks, and its use in cosmetics—especially as a preservative—has been a longstanding public health concern internationally. The Regulations therefore set quantitative limits on mercury and mercury compounds, and they classify non-compliant products as “unwholesome cosmetic products” for the purposes of the Health Products Act.
Although the Regulations are narrow in scope (they apply only to the specified import/export scenarios), they are legally significant because they connect cosmetic product composition requirements to the broader enforcement architecture of the Health Products Act. This means that compliance is not merely a technical matter; it can trigger legal consequences under the Act if a product is treated as unwholesome.
What Are the Key Provisions?
1. Citation and commencement (Regulation 1)
The Regulations are cited as the Health Products (Cosmetic Products — Import for Re-export and Manufacture for Export) Regulations 2019 and come into operation on 1 January 2020. For practitioners, this matters for determining the applicable legal regime for shipments, manufacturing batches, and compliance documentation created before and after commencement.
2. Definition and application (Regulation 2)
Regulation 2(1) provides that “cosmetic product” has the meaning given in the second column of item 2 of the First Schedule to the Health Products Act. This cross-reference is important: the classification of a product as a “cosmetic product” is not determined solely by the Regulations; it is anchored in the Act’s definitional framework.
Regulation 2(2) then limits the Regulations’ application to two categories of products:
- Imported solely for re-export (Regulation 2(2)(a)); or
- Manufactured in Singapore solely for export (Regulation 2(2)(b)).
This “solely” language is a compliance fulcrum. If a product is imported or manufactured for any domestic supply in Singapore (even partially), the Regulations may not be the correct instrument, and other regulatory requirements under the Health Products Act and related subsidiary legislation could apply. Lawyers advising importers/exporters should therefore pay close attention to contractual arrangements, distribution plans, and licensing/permit conditions that demonstrate the “solely for re-export” or “solely for export” purpose.
3. Mercury content of cosmetic products (Regulation 3)
Regulation 3 is the core substantive provision. It establishes two mercury-related restrictions, depending on whether the cosmetic product is “specified” in the Schedule.
(a) General prohibition for non-specified products (Regulation 3(1))
A cosmetic product other than a cosmetic product specified in the first column of Part 1 of the Schedule must not contain mercury or any compound of mercury in excess of one part per million (1 ppm) by weight.
In plain terms: if the product is not among the “specified” categories, the maximum total mercury (including mercury compounds) is capped at 1 ppm by weight. Practitioners should note that the limit is expressed as a concentration threshold, and the wording covers both elemental mercury and mercury compounds, which broadens the compliance scope.
(b) Preservative-specific prohibition for specified products (Regulation 3(2))
For cosmetic products specified in the first column of Part 1 of the Schedule, the prohibition is more nuanced. Such products must not contain, as a preservative, any compound of mercury specified opposite in the second column, in excess of the limit specified opposite in the third column.
This structure indicates that the Schedule identifies particular mercury compounds and sets compound-specific maximum limits for use as preservatives in specified product types. Accordingly, compliance is not only about total mercury concentration; it also requires product-type and preservative-ingredient mapping against the Schedule.
(c) Legal classification as “unwholesome” (Regulation 3(3))
Regulation 3(3) provides the enforcement bridge. A cosmetic product that does not comply with Regulation 3(1) or (2) is an unwholesome cosmetic product for the purposes of section 2(2)(d)(iv) of the Health Products Act.
This is a critical legal consequence. By deeming non-compliant products “unwholesome,” the Regulations ensure that the broader prohibitions, offences, and regulatory powers under the Health Products Act can be invoked. Even though the Regulations focus on import for re-export and manufacture for export, the “unwholesome” classification means that non-compliance can have legal ramifications in Singapore.
4. The Schedule (Mercury content of cosmetic products)
The Schedule operationalises Regulation 3(2) by listing:
- In the first column: the cosmetic products specified in Part 1; and
- In the second and third columns: the mercury compound(s) that may be used as preservatives and the corresponding maximum limits.
Because the Schedule is integral to the preservative-specific rule, counsel should treat it as a mandatory compliance reference. In practice, this requires ingredient-level analysis (what preservative is used, and in what form) and quantitative testing or documentation to demonstrate that the mercury compound concentration does not exceed the Schedule’s limit.
How Is This Legislation Structured?
The Regulations are structured in a compact form:
- Regulation 1: Citation and commencement (1 January 2020).
- Regulation 2: Definition and application, including the cross-reference to the Health Products Act definition of “cosmetic product” and the limited scope for import/re-export and manufacture/export.
- Regulation 3: Mercury content requirements, including general 1 ppm limit for non-specified products, preservative-specific limits for specified products, and the “unwholesome” classification for non-compliance.
- The Schedule: Mercury content of cosmetic products—specifying which product types are “specified” and the mercury preservative compounds and limits applicable to them.
For practitioners, the structure is straightforward but the cross-references are legally important: the definition of “cosmetic product” is imported from the Health Products Act, and the “unwholesome” consequence is linked to section 2(2)(d)(iv) of the Act.
Who Does This Legislation Apply To?
The Regulations apply to parties dealing with cosmetic products that fall within the defined scope—specifically, cosmetic products that are either imported into Singapore solely for re-export or manufactured in Singapore solely for export. While the text does not list particular licence holders or named categories of regulated persons, the practical compliance obligations will typically fall on importers, exporters, manufacturers, and their compliance functions (including quality assurance and regulatory affairs) who ensure that products entering or leaving Singapore meet the mercury limits.
Because the Regulations apply only to the “solely” import/export scenarios, businesses must be able to substantiate their intended commercial use. If a product is intended for Singapore distribution, the legal analysis may shift to other provisions under the Health Products Act and other subsidiary regulations governing cosmetic products generally. Counsel should therefore confirm the business model and supply chain before advising on which regulatory instrument governs.
Why Is This Legislation Important?
First, the Regulations impose a clear, measurable safety standard for mercury in cosmetics, even where the products are not meant for the Singapore consumer market. This reflects a public health approach: Singapore regulates the composition of cosmetic products passing through its jurisdiction to reduce the risk of harmful products being introduced into circulation, whether domestically or through re-export channels.
Second, the “unwholesome cosmetic product” deeming provision in Regulation 3(3) is legally consequential. It means that non-compliance is not merely a breach of a technical requirement; it triggers the statutory concept of “unwholesome” under the Health Products Act. In turn, that concept can activate enforcement mechanisms and potential liability under the Act’s broader framework.
Third, the Schedule-based preservative limits require ingredient-specific compliance. For lawyers advising manufacturers or importers, this typically translates into a need for robust documentation: formulation records, supplier declarations, and testing or analytical evidence demonstrating mercury compound concentrations are within the Schedule limits. It also requires careful product classification—whether the product is “specified” in the Schedule determines whether the general 1 ppm rule or the preservative-specific rule applies.
Related Legislation
- Health Products Act (Cap. 122D) — including the definition of “cosmetic product” and the “unwholesome cosmetic product” concept in section 2(2)(d)(iv)
- Health Products (Cosmetic Products — Import for Re-export and Manufacture for Export) Regulations 2019 (this instrument) — SL 656/2019
Source Documents
This article provides an overview of the Health Products (Cosmetic Products — Import for Re-export and Manufacture for Export) Regulations 2019 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.